bullet Sensors & Transducers Journal

    (ISSN: 2306-8515, e-ISSN 1726-5479)

205.767

2008 e-Impact Factor

25 Top Downloaded Articles

Best Selling Articles 2012

Journal Subscription 2014

Editorial Calendar

Submit an Article

Editorial Board

Current Issue

S&T journal's cover

Sensors & Transducers Journal 2011

Sensors & Transducers Journal 2010

Sensors & Transducers Journal 2009

Sensors & Transducers Journal 2008

Sensors & Transducers Journal 2007

2000-2002 S&T e-Digest Contents

2003 S&T e-Digest Contents

2004 S&T e-Digest Contents

2005 S&T e-Digest Contents

2006 S&T e-Digest Contents

 

Best Articles 2011

 

 

 

Vol. 27, Special Issue, May 2014, pp. 15-21

 

Bullet

 

A Flexible Label-Free Biosensor Sensitive and Selective to TNF-a: Application for Chronic Heart Failure
 

1 Abdoullatif BARAKET, 1 Michael LEE, 1 Nadia ZINE, 2 Nourdine YAAKOUBI, 3 Maria Giovanna TRIVELLA, 4 Abdelhamid ELAISSARI,
4
Monique SIGAUD, 1 Nicole JAFFREZIC-RENAULT, 1 Abdelhamid ERRACHID

1 Institut des Sciences Analytiques (ISA), Université Lyon, Université de Claude Bernard Lyon 1, UMR 5280, 5 rue de la Doua, 69100 Villeurbanne, 6 France
2 Université du Maine UMR CNRS 6613, rue Olivier Messiaen, 72085, LE MANS Cedex 9, France
3 CNR (Consiglio Nazionale Ricerche) Clinical Physiology Institute, Pisa, Italy
4 Université de Lyon, Université Claude Bernard Lyon-1, CNRS, UMR 5007, LAGEP, F-69622 Villeurbanne, France

E-mail: a.baraket@gmail.com, abdelhamid.errachid@univ-lyon1.fr

 

Received: 31 December 2012 /Accepted: 22 November 2013 /Published: 26 May 2014

Digital Sensors and Sensor Sysstems

 

Abstract: Tumor necrosis factor-a (TNF-a) is a key pro-inflammatory cytokine that is characterized by elevated circulating levels for chronic heart failure (CHF) and left ventricular assisted device (LVAD) implantation patients, respectively. Therefore, a rapid and ease-of-use diagnostic tool is required to monitor LVAD patients at a high risk of mortality during early expression of an inflammatory storm. In this paper, we report on the quantitative electrochemical detection of human TNF-a with its corresponding antibody (Ab) immobilized onto the functionalized biosensor surface. The label-free biosensor was fabricated on a gold surface that was deposited on a flexible polyimide (PI) substrate. The interfacial properties of the functionalized flexible gold electrodes were evaluated by cyclic voltammetry (CV) in the presence of Fe(CN)64-/3- as the redox-active species. Afterwards, the electrochemical impedance spectroscopy (EIS) technique was used to determine the TNF-a) concentrations. EIS results confirmed that the developed flexible biosensor can accurately detect TNF-a with a good sensitivity in the dynamic range of 0.1 pg/mL to 0.5 ng/mL. Overall, the developed flexible biosensor was easy to fabricate and the results demonstrate a good selectivity in the presence of other cytokines such as interleukin: (IL-10) and (IL-1).

 

Keywords: Tumor necrosis factor-a), Flexible gold electrodes, Electrochemical impedance spectroscopy.

 

Acrobat reader logo Click <here> or title of paper to download the full pages article in pdf format

 

 

Subscribe the full-page Sensors & Transducers journal in print (paper) or pdf formats

(shipping cost by standard mail for paper version is included)

(25 % discount for IFSA Members)

 

 

 

Alternatively we accept a money transfer to our bank account. Please contact for details: sales@sensorsportal.com

 

 

Download <here> the Library Journal Recommendation Form

 

 

Read more about Biosensors

 

 

 

 

 


1999 - 2014 Copyright ©, International Frequency Sensor Association (IFSA) Publishing, S.L. All Rights Reserved.


Home - News - Links - Archives - Tools - Voltage-to-Frequency Converters - Standardization - Patents - Marketplace - Projects - Wish List - e-Shop - Sensor Jobs - Membership - Videos - Publishing - Site Map - Subscribe - Search

 Members Area -Sensors Portal -Training Courses - S&T Digest - For advertisers - Bookstore - Forums - Polls - Submit Press Release - Submit White Paper - Testimonies - Twitter - Facebook - LinkedIn